首页> 外国专利> STEROIDS OF THE ANDROST-9 SERIES (11) -INES REPLACED WITH HALOGEN IN C-19, REPLACED IN POSITION 5 OR CONDENSED WITH CARBOCICLES IN POSITIONS 6.10, PROCEDURE FOR THEIR PREPARATION, AS WELL AS ITS USE.

STEROIDS OF THE ANDROST-9 SERIES (11) -INES REPLACED WITH HALOGEN IN C-19, REPLACED IN POSITION 5 OR CONDENSED WITH CARBOCICLES IN POSITIONS 6.10, PROCEDURE FOR THEIR PREPARATION, AS WELL AS ITS USE.

机译:Sterosd of ANDROST-9 SERIESDS(11)-在C-19中用卤代烷替换的氨基酸,在位置5处替换的碳素或在位置6.10处带有碳的缩合物,其制备方法及其用途。

摘要

Compounds of the general formula II, with the radical R in the meaning of: R = - (CH2) n-CH2-R1, - (CH2) n-CH2-OR1, - (CH2) n-CH2-OCOR1, - ( CH2) n-CH2-SR1, - (CH2) n-CH2-NR1R2, - (CH2) n-CHO, - (CH2) n-CN, where n can adopt the values of 0-5, and the radicals R1 and R2 represent, independently of one another, hydrogen or a linear or branched, saturated or unsaturated hydrocarbyl radical, with up to 18 C atoms, this radical may eventually contain additional functional groups and carbocyclic or heterocyclic ring elements.
机译:具有基团R的通式II化合物的含义为:R =-(CH2)n-CH2-R1,-(CH2)n-CH2-OR1,-(CH2)n-CH2-OCOR1,-( CH2)n-CH2-SR1,-(CH2)n-CH2-NR1R2,-(CH2)n-CHO,-(CH2)n-CN,其中n可以采用0-5的值,基团R1和R 2彼此独立地代表氢或具有至多18个C原子的直链或支链的饱和或不饱和烃基,该基团最终可包含额外的官能团和碳环或杂环元素。

著录项

  • 公开/公告号ES2287022T3

    专利类型

  • 公开/公告日2007-12-16

    原文格式PDF

  • 申请/专利权人 BAYER SCHERING PHARMA AKTIENGESELLSCHAFT;

    申请/专利号ES20000954359T

  • 申请日2000-07-17

  • 分类号A61K51;C07J1;A61K31/565;A61K31/566;A61K31/568;A61P5/32;A61P5/36;A61P13/08;A61P35;C07B59;C07J21;C07J43;C07J51;C07J53;C07J71;G01N33/60;

  • 国家 ES

  • 入库时间 2022-08-21 20:04:26

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号